P. Werner et al., Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage, ANN NEUROL, 50(2), 2001, pp. 169-180
Glutamate excitotoxicity, recently demonstrated in an animal model of multi
ple sclerosis (MS), is evoked by altered glutamate homeostasis. In the pres
ent study, we investigated the major regulating factors in glutamate excito
toxicity by immunohistochemistry in MS and control white matter with marker
s for glutamate production (glutaminase), glutamate transport (GLAST, GLT-1
and EAAT-1), glutamate metabolism (glutamate dehydrogenase [GDH] and gluta
mine synthetase [GS]), axonal damage (SMI 32) and CNS cell types. Active MS
lesions showed high-level glutaminase expression in macrophages and microg
lia in close proximity to dystrophic axons. Correlation between glutaminase
expression and axonal damage was confirmed experimentally in animals. Whit
e matter from other inflammatory neurologic diseases displayed glutaminase
reactivity, whereas normals and noninflammatory conditions showed none. All
three glutamate transporters were expressed robustly, mainly on oligodendr
ocytes, in normal, control and MS white matter, except for GLT-1, which sho
wed low-level expression around active MS lesions. GS and GDH were present
in oligodendrocytes in normal and non-MS white matter but were absent from
both active and chronic silent MS lesions, suggesting lasting metabolic imp
ediments. Thus, imbalanced glutamate homeostasis contributes to axonal and
oligodendroglial pathology in MS. Manipulation of this imbalance may have t
herapeutic import.